Cleavage and inactivation of Factor IX by granulocyte elastase
- PMID: 6605369
- PMCID: PMC370459
- DOI: 10.1172/JCI111130
Cleavage and inactivation of Factor IX by granulocyte elastase
Abstract
Radioiodinated Factor IX was cleaved by a crude sonicate from leukocytes. In the absence of calcium, fragments of less than 15,000 mol wt were seen from reduced samples on gel electrophoresis. After digestion in 2 mM calcium, however, electrophoresis of reduced samples showed, in addition to low molecular weight fragments, protein bands corresponding in size to heavy and light chains of Factor XIa-activated Factor IX. The cleaving activity in leukocyte sonicates was inhibited by soybean trypsin inhibitor, but only to a small extent by aprotinin. Granulocyte elastase was isolated from purified polymorphonuclear leukocyte granules by affinity chromatography on soybean trypsin inhibitor-agarose and further chromatography on carboxymethyl cellulose. The purified fraction contained two isozymes on acidic gels which cleaved both an ester sensitive to elastase and radiolabeled Factor IX. These two activities were inhibited by elastase-specific chloromethyl ketone. The isolated protease fraction rapidly inactivated apparent Factor IX activity in a coagulant assay system. The degree of inactivation correlated with the amount of intact, radiolabeled Factor IX cleaved. As with the crude sonicate, generation of the larger heavy and light chain-sized fragments was dependent upon calcium. To assess directly the effect of elastase on Factor IX, an immunospecific, active site-directed assay was developed. In this assay, the sample was incubated with solid-phase antibody to Factor IX and the amount of activated product was detected as that which had complexed with radioiodinated antithrombin III. In this system, exposure of Factor IX to Factor XIa showed progressive increase in the ability to bind antithrombin III, whereas after elastase, Factor XIa was unable to generate antithrombin III binding. The elastase-degraded Factor IX did not inhibit activation of additional Factor IX in clotting assays. When Factor IXa was incubated with elastase, binding of antithrombin III was decreased, corresponding to appearance of low molecular weight fragments on parallel samples that were reduced and electrophoresed. These data are consistent with elastase inactivating Factor IX by cleaving bonds near, but distinct from, bonds cleaved by Factor XIa.
Similar articles
-
Cleavage and activation of human factor IX by serine proteases.Blood. 1984 Oct;64(4):821-31. Blood. 1984. PMID: 6383497
-
Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.Blood. 1998 Aug 15;92(4):1287-96. Blood. 1998. PMID: 9694717
-
Substrate-dependent modulation of the mechanism of factor XIa inhibition.Biochemistry. 2004 Sep 21;43(37):11883-8. doi: 10.1021/bi048964g. Biochemistry. 2004. PMID: 15362874
-
Factor IX of the blood coagulation system: a review.Biochemistry (Mosc). 1997 Jul;62(7):685-93. Biochemistry (Mosc). 1997. PMID: 9331959 Review.
-
Activation of factor IX by factor XIa.Trends Cardiovasc Med. 2000 Jul;10(5):198-204. doi: 10.1016/s1050-1738(00)00070-0. Trends Cardiovasc Med. 2000. PMID: 11282295 Review.
Cited by
-
Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.Int J Pancreatol. 1998 Aug;24(1):9-17. doi: 10.1007/BF02787525. Int J Pancreatol. 1998. PMID: 9746884 Clinical Trial.
-
Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions.J Clin Invest. 1986 Jun;77(6):1939-51. doi: 10.1172/JCI112523. J Clin Invest. 1986. PMID: 3519684 Free PMC article.
-
Granulocyte elastase cleaves human high molecular weight kininogen and destroys its clot-promoting activity.J Exp Med. 1988 Jun 1;167(6):1895-907. doi: 10.1084/jem.167.6.1895. J Exp Med. 1988. PMID: 3260266 Free PMC article.
-
Proteolytic inactivation of human leukocyte elastase.Experientia. 1985 May 15;41(5):638-40. doi: 10.1007/BF02007697. Experientia. 1985. PMID: 3846535
-
Emerging and future therapies for hemophilia.J Blood Med. 2015 Sep 3;6:245-55. doi: 10.2147/JBM.S42669. eCollection 2015. J Blood Med. 2015. PMID: 26366108 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials